This is a significant development, and indicates that even if patients are not experiencing symptoms, their hip could still be failing.
New York, New York (PRWEB) January 09, 2013
Stryker is now advising that all patients impacted by the July 2012 Stryker hip recall undergo blood tests for Stryker hips, as well as cross section imaging, even if they are not experiencing symptoms of a failing hip implant, Bernstein Liebhard LLP reports. According to a recent posting on Stryker’s website, repeat follow-up examination, such as blood work and cross section imaging, should be considered for all patients with Stryker Rejuvenate and ABG II hip stems, even in the presence of normal initial finding.*
“This is a significant development, and indicates that even if patients are not experiencing symptoms, their hip could still be failing. It’s important patients affected by the Stryker Rejuvenate recall discuss this issue with their doctors as soon as possible,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is currently offering free legal consultations to all patients affected by the Stryker hip recall.
Stryker Rejuvenate Recall
The Stryker hip recall was announced in July 2012, after data indicated the Rejuvenate and ABG II modular hip stems were vulnerable to fretting and corrosion at the modular-neck junction. According to Stryker’s most recent recall update, the company has received reports of patients with mild or no symptoms that have tested positive for elevated metal ion levels or been diagnosed with adverse local tissue reaction. As such, the company is now recommending blood tests for Stryker hips, as well as imaging tests, regardless of symptoms.**
Stryker also announced that it has retained Broadspire Services, Inc., a third-party claims administrator, to work directly with patients to manage medical claims and address out-of-pocket costs relating to the Stryker rejuvenate recall. According to the website, Stryker has provided doctors with a sample letter they can use to inform patients of the Stryker Broadspire claims program.*** Bernstein Liebhard LLP is advising patients that they should consider speaking with an attorney before they begin the Broadspire Stryker claims process, as any information they disclose to a Broadspire representative could be used as evidence in their Stryker hip lawsuit.
Individuals who have endured hip implant failures, metal poisoning, pain, or revision surgery allegedly due to the Rejuvenate and ABG II modular neck-stems may be entitled to file a Stryker hip recall lawsuit seeking compensation for their medical care, pain and suffering, and other damages. Bernstein Liebhard LLP is offering free lawsuit consultations to anyone affected by the Stryker Rejuvenate recall, including individuals with questions regarding Stryker Broadspire claims. A wealth of information is also available at the firm’s Stryker hip recall lawsuit website. Free case evaluations can be obtained by calling 877-779-1414.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Amy L. Abate. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP